{"cluster": 48, "subcluster": 75, "abstract_summ": " In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan, China . Patients with abnormal liver biochemistries showed higher percentages of severe cases and comorbidities and were more likely to have dyspnea, chest distress or pain ."}